TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

Similar documents
HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region

TB-HIV in the South-East Asia Region

Drug resistance in tuberculosis in South-East Asia

TB epidemic and progress towards the Millennium Development Goals

Estimates of TB incidence, prevalence and mortality. Philippe Glaziou Cairo, October 2009

Estimating the global burden of tuberculosis. WHO estimates of TB incidence, prevalence and mortality, by country,

Tuberculosis Control

Tuberculosis Control. in the South-East Asia Region

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases

Tuberculosis Surveillance and Monitoring

The epidemiology of tuberculosis

Tuberculosis Control

Tuberculosis in the SAARC Region An Update 2007

7.5 South-East Asian Region: summary of planned activities, impact and costs

TUBERCULOSIS CONTROL SAARC REGION

Regional Response Plan for TB-HIV

STATUS OF EAR AND HEARING CARE IN SOUTH EAST ASIA REGION

Population. B.4. Malaria and tuberculosis

SEA-TB-315 Distribution: General. Tuberculosis. in the South-East Asia Region

Measles and Rubella Fact Sheet SEAR #

Global TB control: Current status with particular attention to TB among women and children

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

WHO Global Task Force on TB Impact Measurement An overview

Global, National, Regional

Investing for Impact

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Measuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT

What can be done against XDR-TB?

Global, National, Regional

World Health Organization 2013

TB surveillance. Philippe Glaziou Dubrovnik, May 2009

The WHO END-TB Strategy

REVIEW OF TUBERCULOSIS EPIDEMIOLOGY

TB Situation in Zambia/ TB Infection Control Program. Dr N Kapata Zambia National TB/Leprosy Control Programme Manager

TB Disease Prevalence Survey - Progress Report

HIV / AIDS & HUMAN RIGHTS

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan

Antimalarial drug resistance

Policy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis

3.1 PHASE 2 OF THE GLOBAL PROJECT

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager

Drug-resistant Tuberculosis

South-East Asia Regional Committee resolution (September 2013, New Delhi)

Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Regional Consultation on the Social Determinants of Health WHO/SEARO, New Delhi, September, 2005

Draft Programme (05 May 2016)

Current situation and capacity in the South-East Asia Region

The Western Pacific Region faces significant

Rotavirus: WHO Global Recommendations, Policy, and Surveillance

SAARC Regional Strategy for Control/Elimination of Tuberculosis

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Immunization and Vaccine Development (IVD) SEARO

Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO

511,000 (57% new cases) ~50,000 ~30,000

TUBERCULOSIS CONTROL SAARC REGION

Immunization and Vaccine Development (IVD) SEARO

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report

Emerging Infectious Diseases Australia is not an Island

TUBERCULOSIS CONTROL SAARC REGION

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers

TB Disease Prevalence Survey - Overview and Introduction of the TF

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO

TB/HIV Project in the Philippines. Yumiko Yanase

Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO. UNESCAP Forum, New Delhi: 17 Feb 2012

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

Helping TB patients quit smoking: the potential impact, WHO recommendations and country experience

PROGRESS ON IMPLEMENTATION OF THE 3Is IN SOUTH AFRICA. Yogan Pillay Deputy Director General Strategic Health Programmes South Africa

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

Population. B.3. HIV and AIDS. There has been mixed progress in reducing new HIV infections and AIDSrelated

Global reductions in measles mortality and the risk of measles resurgence

HIV & AIDS IN THE SAARC REGION

Progress towards achieving Millennium Development Goal 5 in South-East Asia

Strengthening Veterinary Services in Asia

Progress reports on selected Regional Committee resolutions:

Updated Regional Strategic Plan for TB Care and Control SEA-TB-345 Distribution: General

TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2005

Mozambique Draft 3Is workplan

TUBERCULOSIS CONTROL WHO WESTERN PACIFIC REGION

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

Nutrition Profile of the WHO South-East Asia Region

Performance of RNTCP NTI Bulletin 2005,41/3&4,

Childhood malnutrition in Asia: numbers count but do we care?

Session-1: Template for country presentation (EXISTING Indicators)

Hypertension in the South-East Asia Region: an overview

~'UU':i~"llln':ibn~ii~'\AJ ~~U':i~b'Vl1"f1'VlCJ'Vh1~'U':i':iabU1Vl:lJ1CJ~~ 2 ~d~1~bb~d1'uu'\aj.i"f. 2558

Global burden and costeffective. tobacco control" Dr Douglas Bettcher Director Prevention of Noncommunicable Diseases World Health Organization

Tuberculosis Screening and IPT: Experience from India

Drug-resistant Tuberculosis

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

The WHO global TB database

C R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership

Current Status of Dengue/Dengue Haemorrhagic Fever in WHO South-East Asia Region

Overview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities

The Millennium Development Goals and Sri Lanka

Doctors with Africa CUAMM

Transcription:

TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5% Americas 4% African Region 28% European Region 4% South-East Asia Region 34% 4.8 million cases 538,000 deaths/year Western Pacific Region 25% Global Burden: 13.7 million TB cases; 2 million TB deaths

The numbers: All forms of TB Estimated number of cases 4.88 million Number on treatment as reported by NTPs in 2008 >2.2 million Multidrug-resistant TB (MDR-TB) > 150,000/yr ~ 1000 Extensively drugresistant TB (XDR-TB) NA <10 HIV-associated TB ~ 120, 000/yr ~ 6000 on ATT+ CPT +ART Adapted from a slide provided by Dr. Paul Nunn, WHO Geneva

Source: Annual Reports on TB control, National TB Programmes, SEAR Member Countries, December 2008 Case detection and treatment success rates, SEAR countries, 1997 to 2007 100 95 90 85 80 75 70 65 60 55 Treatment success rate (%) 50 CDR: 69%; TSR: 87% Target zone 0 10 20 30 40 50 60 70 80 90 100 Case detection rate (%) 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

20 280,000 18 16 14 12 10 8 6 4 2 0 Established Market Economies Central Europe Eastern Europe Latin America Eastern Mediterranean Region Africa low HIV incidence Africa high HIV incidence South-east Asia Western Pacific Region MDR-TB % MDR-TB number MDR TB Burden Among All Cases by Regions % of MDR-TB Number of MDR-TB 28% of the global burden of MDR-TB 260,000 240,000 220,000 200,000 180,000 160,000 140,000 120,000 100,000 80,000 60,000 40,000 20,000 0

Review of country plans and progress made since last workshop in 2006

Bangladesh-Planned 2006 Surveillance Survey Improve recording and reporting system and compilation of data To establish a baseline survey by 2009

Bangladesh-Progress made Case notification rates increased steadily until 1997 From 1998 till 2001, a flat or even falling pattern, while increase after 2001 Increases due to improved case finding attributable to geographic expansion and intensified collaboration with NGOs. The observed variations are due to changes in case finding and not a true rise in incidence Soft ware for data collection and analysis developed Population based survey initiated in 2007 and preliminary results available

Bhutan-Planned 2006 Surveillance Survey To refine TB information system by revising the current recording and reporting system by 2007 ARTI survey by the end of 2007

Bhutan-Progress made High notification of extra pulmonary TB Low number of smear negative TB Revision of recording and reporting system undertaken

DPR Korea-Planned 2006 Surveillance Survey Revision of recording and reporting forms and computerization at central, provincial and county levels gradually ARTI surveys in three province by 2010-2011

DPR Korea-Progress made Recording and reporting forms revised Soft ware developed at the central level and functional ARTI surveys conducted in three provinces in 2007; ARTI represents 3.1%

India-Planned 2006 Surveillance Survey National roll-out of EPIENTER to be completed by mid 2008; Enhancing data management capabilities at district/state/central levels; Training of trainers and planned roll-out of training; Electronic patient based information for DOTS-Plus cases Prevalence surveys in six sites to be completed by 2010; Tuberculin testing baseline data information available by 2010

India-Progress made Revised R&R and Windows based EpiCentre introduced late 2008 / DOS-based system to be phased out by end 2009 On-going MIFA (Managing Information For Action) training of trainers course to enhance data management capabilities at district/state/ central levels since 2008 Electronic patient based information for DOTS-Plus being developed Disease prevalence surveys on-going in seven sites, where screening is done through X-ray and symptom elicitation in 3 sites and with symptom elicitation alone in 4 sites, followed by smear and culture field enrollment expected to be completed by end 2009 2 nd National ARTI survey on-going in 4 zones, field enrollment expected to be completed by March 2010 W1

Slide 18 W1 As decided upon by a National level Expert Committee. Also the Committee produced an estimate of the disease prevalence for the country for the year 2000. Waresf, 2009-07-17

Indonesia-Planned 2006 Surveillance Survey Improvement of electronic TB software Inclusion of surveillance data, update provincial profiles and upload TB website Tuberculin survey in 3 epidemiological zones; TB mortality study in 6 provinces; TB/HIV sero-prevalence study in 6 provinces; Repeat national TB prevalence study in 2010

Indonesia-Progress made 2004 TB Prevalence Survey show that the prevalence and incidence rates for Indonesia are 119 per 100,000 and 110 per 100,000 respectively National Institute for Health Research and Development (NIHRD- MOH) carried-out mortality survey in ten sub districts located in three main project sites representing metropolitan areas (Jakarta), urban areas (Surakarta) and rural areas (Pekalongan district), covering a total population of about 1 million, estimated to yield about 7000 deaths annually. The one year mortality data (2006) in Pekalongan district shows that TB was ranked as the sixth highest (6%) contributor for leading causes of death

Indonesia-Progress made HIV prevalence survey among TB patients in 5 provinces (Jakarta, West Java, East Java, Bali and Papua) Tuberculin Surveys in South Kalimantan and North Sulawesi Provinces of Indonesia to Estimate the Annual Risk of Tuberculosis Infection (ARTI), being implemented by University of Indonesia in collaboration with WHO Drug Resistance Survey in East Java Province is the second DRS in Indonesia using the same method with the first one in Central Java province done in 2006 is being conducted by NTP with support from KNCV, IMVS Australia and WHO

Maldives-Planned 2006 Surveillance Survey Set up of uniform excel format in the central office by 2008 Measure the duration of disease for better assessment of the prevalance

Maldives-Progress made Overall trend consistently downward across all age groups Rate of decline has decreased from 10% per year earlier to 1-2% currently Central uniform excel format in the process of development

Myanmar-Planned 2006 Surveillance Survey Computerized recording and reporting system using STAR by 2007-08; Establish mortality data base system linked with existing vital registration by first quarter 2007 Continuation of point prevalence survey in remaining parts of the country by 2008 and repeat in 2013-14

Myanmar-Progress made Routine sentential surveillance among new TB patients are in place Results of TB prevalence survey in Yangon Division in 2006 showed incidence of TB 2.26 times higher than the current WHO estimates DHIS software were introduced in central, state and divisional levels Staff trained on data management

Nepal-Planned 2006 Surveillance Survey Strengthening of data management system using EPICENTER by middle of 2007 Mortality from observation on patient cohorts by 2008

Nepal-Progress made Case notifications are rather flat following the period of DOTS expansion, which may signify that case finding is good but the incidence is apparently not decreasing Tuberculin survey was conducted, ARTI 0.6% indicating decrease in transmission or over estimation of previous estimates Sentinel surveys of HIV among TB patients conducted in 2006-07 show a prevalence of 2.4%

Sri Lanka-Planned 2006 Surveillance Survey Developing software on supervision, on going meetings, cross recording and reporting in TB/HIV Tuberculin survey by 2007 Drug resistant survey by 2010-11

Sri Lanka-Progress made Minimal change in over all case notification rates However, increase in the age group 15-24 years, particularly among males ARTI is on going and the preliminary results available by the end of July 2009

Thailand-Planned 2006 Surveillance Survey Epidemiological situation analysis; Electronic recording and reporting system; Strengthening supervision, monitoring and evaluation in large hospitals by 2008 Not planned

Thailand-Progress made Epidemiological situation analysis done Electronic recording and reporting introduced in central level Supervision and monitoring strengthened in large hospitals

Timor Leste-Planned 2006 Surveillance Survey Develop regional supervision and monitoring plan; Introduction of training on monitoring and evaluation; Quarterly reporting and follow up of new smear positive TB cases registered under DOTS successfully treated; Quality control by 2008 Not planned

Timor-Leste-Progress made In May 2008 based on analysis of national data and other evidence from Indonesia and in particular from province that includes West Timor, and active case finding data from one Sub-district in TLS revised range for incidence of NSP in the country 115 to 175 per 100,000 population An updated excel format has been designed with assistance from WHO to recording national data at central level NTP data 2000-2008 organized into uniform excel format, retrospectively, prospective formats designed till 2012 This allows internal consistency checks, auto generates a quarterly and annual performance report on key indicators, auto-generates relevant graphs, trend analysis Staff at NTP has been trained in the use of this new system

Thank you